GT Biopharma
GTBP
GTBP
17 hedge funds and large institutions have $38.1M invested in GT Biopharma in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$37.8M | |
| 2 | +$53.7K | |
| 3 | +$31.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$22.5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$28 |
Top Sellers
| 1 | -$28.3K | |
| 2 | -$1.03K | |
| 3 | -$362 | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$271 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$55 |